For more than a decade, Ash Tewari, MBBS, MCh, FRCS (Hon.), has been a leader in advancing the safety and precision of robot-assisted radical prostatectomies. That pioneering work is reflected in two new studies that have identified biomarkers for cancer aggressiveness and clinical outcomes and assessed the efficacy and safety of a new approach to prostatectomy.
